Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jun;10(Suppl 17):S2007-S2010.
doi: 10.21037/jtd.2018.05.40.

Surgery vs. SBRT in retrospective analyses: confounding by operability is the elephant in the room

William A Stokes  1 , Chad G Rusthoven  1
Affiliations
Editorial

Surgery vs. SBRT in retrospective analyses: confounding by operability is the elephant in the room

William A Stokes et al. J Thorac Dis. 2018 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Overall survival for stage I NSCLC patients in retrospective comparisons of (A) VATS lobectomy vs. SBRT in a study by Cornwell et al. and (B) SBRT in all patients, stratified by medically operable vs. inoperable status in a study by Onishi et al. Adapted from Cornwell LD et al., J Thorac Cardiovasc Surg 2018;155:395-402, and Onishi H et al., J Thorac Oncol 2007;2:S94-10, presented with permission from the publisher.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Ettinger DS, Wood DE, Aisner DL, et al. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017;15:504-35. 10.6004/jnccn.2017.0050 - DOI - PubMed
    1. Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 2015;16:630-7. 10.1016/S1470-2045(15)70168-3 - DOI - PMC - PubMed
    1. Rusthoven CG, Kavanagh BD, Karam SD. Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data. Ann Transl Med 2015;3:149. - PMC - PubMed
    1. Rusthoven CG, Palma DA, Senan S, et al. The head start effect: will acute and delayed postoperative mortality lead to improved survival with stereotactic body radiation therapy for operable stage I non-small-cell lung cancer? J Clin Oncol 2017;35:1749-51. 10.1200/JCO.2016.72.0003 - DOI - PubMed
    1. Flores RM. Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery. J Thorac Cardiovasc Surg 2018;155:403-4. 10.1016/j.jtcvs.2017.08.058 - DOI - PubMed

LinkOut - more resources